Insider · CIK 0001834021
David Kirn
Files at FDMT (4D Molecular Therapeutics, Inc.). First filing Sep 16, 2026, latest Oct 7, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
FDMT: 4D Molecular Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 17Weak | 4D Molecular Therapeutics, Inc. | $754k 58,333 shares | -8% | - | |
| 25Weak | 4D Molecular Therapeutics, Inc. | $811k 58,333 shares | -7% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | FDMT 4D Molecular Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -58,061 | $12.92 | $750k | 709,425 | 5 d ago |
| Oct 5, 2026 | FDMT 4D Molecular Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -272 | $13.61 | $3,702 | 709,153 | 5 d ago |
| Sep 14, 2026 | FDMT 4D Molecular Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -58,333 | $13.90 | $811k | 767,486 | 26 d ago |
| Mar 6, 2025 | FDMT 4D Molecular Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +267,500 | $0.00 | $0 | 267,500 | Mar 10, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.